Cargando…
Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2)
BACKGROUND: Charcot-Marie-Tooth neuropathies are a group of genetically heterogeneous diseases of the peripheral nervous system. Mutations in the MFN2 gene have been reported as the primary cause of Charcot-Marie-Tooth disease type 2A. METHODS: Patients with the clinical diagnosis of Charcot-Marie-T...
Autores principales: | Engelfried, Kathrin, Vorgerd, Matthias, Hagedorn, Michaela, Haas, Gerhard, Gilles, Jürgen, Epplen, Jörg T, Meins, Moritz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524942/ https://www.ncbi.nlm.nih.gov/pubmed/16762064 http://dx.doi.org/10.1186/1471-2350-7-53 |
Ejemplares similares
-
Torin1 restores proliferation rate in Charcot-Marie-Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation
por: Zanfardino, Paola, et al.
Publicado: (2022) -
MFN2-related Charcot-Marie-Tooth Disease with Atypical Ocular Manifestations
por: Nan, Haitian, et al.
Publicado: (2021) -
Multiple respiratory complications in a patient with Charcot-Marie-Tooth disease with MFN2 mutation
por: Sano, Tomoya, et al.
Publicado: (2022) -
Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity
por: Beręsewicz, Małgorzata, et al.
Publicado: (2018) -
Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene
por: Vinci, Paolo, et al.
Publicado: (2011)